Pfizer PFE Current Debt
Current Debt at other companies
Other financials
Where this comes from
Reported directly by Pfizer in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtCurrent.
The official record: Pfizer’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pfizer's current debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Pfizer's current debt?
- Pfizer (PFE) reported current debt of $3.86B in Q1 2026.
- How has Pfizer's current debt changed year-over-year?
- Pfizer's current debt increased by 3.0% year-over-year, from $3.75B to $3.86B.
- What is the long-term trend for Pfizer's current debt?
- Over 5 years (2020 to 2025), Pfizer's current debt has grown at a 8.4% compound annual growth rate (CAGR), from $2B to $3B.
- What does current debt mean?
- The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.